Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SMC5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
ATP6V0A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AP5S1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARSK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COL17A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FARP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPM1H - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABCF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NOC2L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SHC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPL37A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRAPPC2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPAIN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZC3H14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EME1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DIS3L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on